Hoth Therapeutics, Inc.
HOTH
$1.20
$0.065.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.16M | -10.29M | -9.80M | -8.47M | -8.05M |
| Total Depreciation and Amortization | 0.00 | 13.00K | 4.40K | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.29M | 1.40M | 1.36M | 804.80K | 580.30K |
| Change in Net Operating Assets | 194.00K | 50.70K | 389.90K | 685.50K | -553.30K |
| Cash from Operations | -9.68M | -8.82M | -8.04M | -6.98M | -8.02M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -300.00K | -- | -- | -- | -- |
| Cash from Investing | -300.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.20M | 8.19M | 11.81M | 4.74M | 3.68M |
| Repurchase of Common Stock | -376.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.82M | 8.19M | 11.81M | 4.74M | 3.68M |
| Foreign Exchange rate Adjustments | -14.60K | -11.10K | -13.00K | -18.30K | 533.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -174.90K | -640.80K | 3.75M | -2.25M | -3.81M |